Publications
Detailed Information
Comparable Survival Between pN0 Breast Cancer Patients Undergoing Sentinel Node Biopsy and Extensive Axillary Dissection: A Report From the Korean Breast Cancer Society
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Moon, Hyeong-Gon | - |
dc.contributor.author | Han, Wonshik | - |
dc.contributor.author | Noh, Dong-Young | - |
dc.date.accessioned | 2012-06-29T06:55:28Z | - |
dc.date.available | 2012-06-29T06:55:28Z | - |
dc.date.issued | 2010-04-01 | - |
dc.identifier.citation | JOURNAL OF CLINICAL ONCOLOGY; Vol.28 10; 1692-1699 | ko_KR |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | https://hdl.handle.net/10371/77974 | - |
dc.description.abstract | Purpose Recent studies showing survival benefit of extensive axillary lymph node dissection (ALND) in pN0 breast cancer have challenged the concept of sentinel node biopsy (SNB). In this study, the survival and recurrence after SNB alone and ALND in pN0 Korean breast cancer patients were investigated. Patients and Methods Using information from two large databases, including a Korean nationwide registry, we assessed survival relative to the extent of ALND in pN0 breast cancer patients. We also compared the survival of pN0 patients who underwent SNB alone with survival in those who underwent varying degrees of ALND. Results In an analysis of 1,607 pN0 patients from a single institution, less extensive ALND significantly increased the risks of breast cancer death and systemic recurrence but not of locoregional recurrence. These findings were validated by an analysis of nationwide registry data on 17,672 pN0 patients; patients with > 20 dissected lymph nodes had significantly better overall survival (OS) and breast cancer-specific survival (BCSS) than those with 10 to 20 or < 10 dissected lymph nodes. Patients who underwent SNB alone showed OS (hazard ratio [HR], 1.03; 95% CI, 0.08 to 1.56) and BCSS (HR, 1.15; 95% CI, 0.75 to 1.78) similar to those of patients who underwent extensive ALND (> 20 dissected lymph nodes), despite the small number of lymph nodes removed. Conclusion Extensive ALND is associated with better survival and less systemic recurrence than less extensive ALND in patients with pN0 breast cancer. However, SNB alone showed excellent survival results, similar to those of extensive ALND, supporting the long-term oncologic safety of SNB. J Clin Oncol 28: 1692-1699. (C) 2010 by American Society of Clinical Oncology | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | AMER SOC CLINICAL ONCOLOGY | ko_KR |
dc.title | Comparable Survival Between pN0 Breast Cancer Patients Undergoing Sentinel Node Biopsy and Extensive Axillary Dissection: A Report From the Korean Breast Cancer Society | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 문형곤 | - |
dc.contributor.AlternativeAuthor | 한원식 | - |
dc.contributor.AlternativeAuthor | 노동영 | - |
dc.identifier.doi | 10.1200/JCO.2009.25.9226 | - |
dc.citation.journaltitle | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.description.citedreference | Canavese G, 2009, ANN ONCOL, V20, P1001, DOI 10.1093/annonc/mdn746 | - |
dc.description.citedreference | Veronesi U, 2009, EUR J CANCER, V45, P1381, DOI 10.1016/j.ejca.2008.11.041 | - |
dc.description.citedreference | Sanghani M, 2009, CANCER, V115, P1613, DOI 10.1002/cncr.24174 | - |
dc.description.citedreference | Maaskant AJG, 2009, BREAST CANCER RES TR, V113, P173, DOI 10.1007/s10549-008-9913-8 | - |
dc.description.citedreference | Axelsson CK, 2009, BRIT J SURG, V96, P40, DOI 10.1002/bjs.6350 | - |
dc.description.citedreference | Zavagno G, 2008, ANN SURG, V247, P207, DOI 10.1097/SLA.0b013e31812e6a73 | - |
dc.description.citedreference | Cufer T, 2008, ANN ONCOL, V19, P41, DOI 10.1093/annonc/mdn439 | - |
dc.description.citedreference | Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4 | - |
dc.description.citedreference | Ahn SH, 2007, J CLIN ONCOL, V25, P2360, DOI 10.1200/JCO.2006.10.3754 | - |
dc.description.citedreference | Benson JR, 2007, LANCET ONCOL, V8, P331 | - |
dc.description.citedreference | Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001 | - |
dc.description.citedreference | Vanderveen KA, 2006, ANN SURG ONCOL, V13, P1450, DOI 10.1245/s10434-006-9109-6 | - |
dc.description.citedreference | Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158 | - |
dc.description.citedreference | Pater J, 2006, J NATL CANCER I, V98, P568, DOI 10.1093/jnci/djj183 | - |
dc.description.citedreference | Smigal C, 2006, CA-CANCER J CLIN, V56, P168 | - |
dc.description.citedreference | Rudenstam CM, 2006, J CLIN ONCOL, V24, P337, DOI 10.1200/JCO.2005.01.5784 | - |
dc.description.citedreference | Henderson IC, 2006, J CLIN ONCOL, V24, P325, DOI 10.1200/JCO.2005.03.6178 | - |
dc.description.citedreference | JEONG J, 2006, J BREAST CANCER, V9, P151 | - |
dc.description.citedreference | Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001 | - |
dc.description.citedreference | Purushotham AD, 2005, J CLIN ONCOL, V23, P4312, DOI 10.1200/JCO.2005.03.228 | - |
dc.description.citedreference | Martelli G, 2005, ANN SURG, V242, P1, DOI 10.1097/01.sla.0000167759.15670.14 | - |
dc.description.citedreference | SHIN HR, 2005, CANC RES TREAT, V37, P325 | - |
dc.description.citedreference | Somner JEA, 2004, J CLIN PATHOL, V57, P845, DOI 10.1136/jcp.2003.015560 | - |
dc.description.citedreference | Louis-Sylvestre C, 2004, J CLIN ONCOL, V22, P97, DOI 10.1200/JCO.2004.12.108 | - |
dc.description.citedreference | Krag DN, 2003, ANN SURG ONCOL, V10, P1152, DOI 10.1245/ASO.2003.03.073 | - |
dc.description.citedreference | Cody HS, 2003, ANN SURG ONCOL, V10, P1131, DOI 10.1245/ASO.2003.10.905 | - |
dc.description.citedreference | Edge SB, 2003, J NATL CANCER I, V95, P1514, DOI 10.1093/jnci/djg076 | - |
dc.description.citedreference | Veronesi U, 2003, NEW ENGL J MED, V349, P546 | - |
dc.description.citedreference | Polednak AP, 2003, ANN SURG, V237, P163 | - |
dc.description.citedreference | Fisher B, 2002, NEW ENGL J MED, V347, P567 | - |
dc.description.citedreference | Weir L, 2002, J CLIN ONCOL, V20, P1793, DOI 10.1200/JCO.2002.07.112 | - |
dc.description.citedreference | Krag D, 2001, AM J SURG, V182, P411 | - |
dc.description.citedreference | Tjan-Heijnen VCG, 2001, BREAST CANCER RES TR, V70, P81 | - |
dc.description.citedreference | Iyer RV, 2000, INT J RADIAT ONCOL, V47, P1177 | - |
dc.description.citedreference | Greco M, 2000, ANN SURG, V232, P1 | - |
dc.description.citedreference | Cady B, 2000, ANN SURG, V232, P8 | - |
dc.description.citedreference | Bland KI, 1999, J AM COLL SURGEONS, V188, P586 | - |
dc.description.citedreference | Orr RK, 1999, ANN SURG ONCOL, V6, P109 | - |
dc.description.citedreference | GIULIANO AE, 1995, ANN SURG, V222, P394 | - |
dc.description.citedreference | GIULIANO AE, 1994, ANN SURG, V220, P391 | - |
dc.description.citedreference | KRAG DN, 1993, SURG ONCOL, V2, P335 | - |
dc.description.citedreference | FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604 | - |
dc.description.citedreference | HARRIS JR, 1985, BREAST CANCER RES TR, V5, P17 | - |
dc.description.tc | 6 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.